ZLDAF
Zelira Therapeutics Limited
Industry
Research and Development in Biotechnology
Loading...
Open
0.40
Mkt cap
5.3M
Volume
2.5K
High
0.47
P/E Ratio
-0.22
52-wk high
0.69
Low
0.40
Div yield
N/A
52-wk low
0.19

Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:05 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.